Vasospastic Syndrome Completed Phase 4 Trials for Triflusal (DB08814)

Back to Vasospastic Syndrome
IndicationStatusPhase
DBCOND0035088 (Vasospastic Syndrome)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01612273The Effect of Triflusal on Peripheral Microcirculation DysfunctionTreatment